Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn.

Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn. Abstract Text:

PURPOSE: That vascular endothelial growth factor (VEGF) plays a major role in inflammatory angiogenesis has been well established. This pilot study was designed to evaluate experimental treatment with bevacizumab eyedrops in corneal neovascularization induced by alkali burn. The feasibility of topical administration, corneal cell viability and corneal penetration were investigated in an animal model. METHODS: Eighteen chinchilla bastard rabbit corneas injured with 1 m NaOH were divided into three groups: untreated, early and late treatment groups. Eyedrops of bevacizumab solution (25 mg/ml) were administered five times daily. Clinical examination under stereoscopic microscope was performed to evaluate corneal opacity, neovascularization, vessel size and oedema. Histopathology was analysed for vessel density and apoptotic reaction. Additionally, intracameral bevacizumab concentration was measured with enzyme-linked immunosorbent assay (ELISA) after repeated topical applications. RESULTS: A fast increase in aqueous bevacizumab concentration was achieved when the solution was instilled every minute onto a healthy eye surface. As well as clear anti-angiogenic effects, anti-fibrotic effects were also seen after corneal burn, maintaining corneal transparency. Early treatment of actively growing vessels showed a significantly better outcome, although apoptosis of pre-existing vessels could also be induced by the late treatment. No specific toxicity was seen regarding epithelium, keratocytes or endothelium. CONCLUSIONS: The data from this pilot study suggest that bevacizumab eyedrops can sufficiently penetrate the corneal stroma and anterior chamber. When administered soon after alkali burn, bevacizumab seems to significantly reduce corneal damage. Combinations of established treatment regimens with topical bevacizumab might be considered in severe injuries with otherwise devastating prognoses.

Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Acta ophthalmologica

VOLUME: 86

Page Numbers: 322-8

Journal Abbreviation:

ISSN: 1755-3768

DAY: 8

MONTH: 11

YEAR: 2007

Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101468102

Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn.

AFFILIATION: Department of Ophthalmology, Eberhard-Karls University Tübingen, Germany.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Acta Ophthalmol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn Related Publications

• August consultation #4.
• Comparative antiproliferative and cytotoxic profile of bevacizumab (Avastin), pegaptanib (Macugen) and ranibizumab (Lucentis) on different ocular cells.
• Effects of bevacizumab on retinal function in isolated vertebrate retina.
• Efficacy of intravitreal bevacizumab in treating postoperative pseudophakic cystoid macular edema.
• Electrophysiological effects of Brilliant Blue G in the model of the isolated perfused vertebrate retina.
• Safety profile of a taurine containing irrigation solution (AcriProTect) in pars plana vitrectomy.
• Safety profile of bevacizumab on cultured human corneal cells.
• Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn.
• Suppression of melanoma-associated neoangiogenesis by bevacizumab.
• The effects of triamcinolone crystals on retinal function in a model of isolated perfused vertebrate retina.
• Toxic effects of recombinant tissue plasminogen activator on cultured human corneal endothelial cells.
• [Optic atrophy subsequent to epiretinal triamcinolone deposits in an eye following inner limiting membrane peeling.]